Posted in | News | Mining Business

Draslovka Completes $521 Million Acquisition of Chemours’ Mining Solutions Business

Draslovka a.s. (“Draslovka” or “the Company”), a Czech Republic-based, global, family-owned leader in CN-based specialty chemicals including next generation fumigants and biocides, today announces that it has completed the acquisition of the Mining Solutions business of The Chemours Company (“Chemours”) for a total consideration of $521 million.

This completion makes Draslovka the world’s largest producer of solid sodium cyanide and a global leader in the manufacture, technological development, and distribution of hydrogen cyanide (HCN) based specialty chemical products. The Company now has operations on three continents – Europe, the Americas, and Australasia – enabling it to provide a best-in-class service to its customers in the mining, agriculture, and diversified industrials sectors across the world.

Draslovka plans to continue its growth trajectory with this enlarged global platform supporting further strategic M&A as well as organic growth as the Company looks to capitalise on a range of opportunities for international expansion, with demand for next-generation CN-based specialty chemical products – such as EDN®, an ozone-friendly alternative to methyl bromide – continuing to increase.

Draslovka raised a $348 million syndicated Term Loan B in November via sole bookrunner J.P. Morgan to support the acquisition of Chemours Mining Solutions business. The Term Loan B and equity from the existing shareholders will be used to fund the acquisition.

Pavel Brůžek, CEO of Draslovka, said:

“We are delighted to announce the completion of this acquisition and to formally welcome our new US employees to Draslovka. 2021 has been a transformative year for our business following over 100 years of organic growth since our founding in 1906. Through this enlarged global platform, we will be better able to serve both new and existing customers, and we plan to invest for growth across our portfolio in support of our ongoing ambitious international expansion plans. We are excited by the prospect of using Draslovka’s market-leading CN-based specialty chemicals expertise and technological know-how to drive improvements in safety and efficiency, enabling us to offer our customers safe and environmentally friendly products as well as our best-in-class customer support and services.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Draslovka Holding a.s.. (2021, December 02). Draslovka Completes $521 Million Acquisition of Chemours’ Mining Solutions Business. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=16795.

  • MLA

    Draslovka Holding a.s.. "Draslovka Completes $521 Million Acquisition of Chemours’ Mining Solutions Business". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=16795>.

  • Chicago

    Draslovka Holding a.s.. "Draslovka Completes $521 Million Acquisition of Chemours’ Mining Solutions Business". AZoMining. https://www.azomining.com/News.aspx?newsID=16795. (accessed November 21, 2024).

  • Harvard

    Draslovka Holding a.s.. 2021. Draslovka Completes $521 Million Acquisition of Chemours’ Mining Solutions Business. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=16795.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.